Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Suven Life Sciences Ltd.
DescriptionOrally active antagonist of serotonin (5-HT6) receptor
Molecular Target Serotonin (5-HT6) receptor
Mechanism of ActionSerotonin (5-HT6) receptor antagonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationAlzheimer's disease (AD)
Indication DetailsTreat Alzheimer's disease (AD); Treat Alzheimer's disease and Schizophrenia
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today